Androgen Excess: Multimedia

References

1. Boyd-Woschinko G, Kushner H, Falkner B. Androgen excess is associated with insulin resistance and the development of diabetes in African American women. J Cardiometab Syndr. Fall 2007;2(4):254-9. [Medline].

2. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. Nov 1961;21:1440-7. [Medline].

3. [Guideline] Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. Apr 2008;93(4):1105-20. [Medline]. [Full Text].

4. [Guideline] The evaluation and treatment of androgen excess. Fertil Steril. Nov 2006;86(5 Suppl 1):S241-7. [Medline].

5. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril. Dec 3 2008;[Medline].

6. Ibanez L, Lopez-Bermejo A, del Rio L, Enriquez G, Valls C, de Zegher F. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab. May 2007;92(5):1710-4. [Medline].

7. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA, Garner SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. Jul 8 2009;CD004425. [Medline].

8. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. Feb 2004;89(2):453-62. [Medline].

9. Balfour JA, McClellan K. Topical eflornithine. Am J Clin Dermatol. 2001;2(3):197-201; discussion 202. [Medline].

10. Barbieri RL. Hyperandrogenic disorders. Clin Obstet Gynecol. Sep 1990;33(3):640-54. [Medline].

11. Carmina E. Mild androgen phenotypes. Best Pract Res Clin Endocrinol Metab. Jun 2006;20(2):207-20. [Medline].

12. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. Jun 1999;84(6):1897-9. [Medline].

13. Falsetti L, De Fusco D, Eleftheriou G. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome. Gynecol Endocrinol. Aug 1997;11(4):251-7. [Medline].

14. Falsetti L, Gambera A. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism. Fertil Steril. Jul 1999;72(1):41-6. [Medline].

15. Friedman CI, Schmidt GE, Kim MH. Serum testosterone concentrations in the evaluation of androgen- producing tumors. Am J Obstet Gynecol. Sep 1 1985;153(1):44-9. [Medline].

16. Goodman NF, Bledsoe MB, Futterweit W, et al. American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract. Mar-Apr 2001;7(2):120-34. [Medline].

17. Guido M, Romualdi D, Giuliani M, et al. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab. Jun 2004;89(6):2817-23. [Medline].

18. Hock DL, Seifer DB. New treatments of hyperandrogenism and hirsutism. Obstet Gynecol Clin North Am. Sep 2000;27(3):567-81, vi-vii. [Medline].

19. Liepa GU, Sengupta A, Karsies D. Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?. Nutr Clin Pract. Feb 2008;23(1):63-71. [Medline].

20. Meyer-Bahlburg HF, Dolezal C, Baker SW, New MI. Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav. Feb 2008;37(1):85-99. [Medline].

21. Moghetti P, Toscano V. Treatment of hirsutism and acne in hyperandrogenism. Best Pract Res Clin Endocrinol Metab. Jun 2006;20(2):221-34. [Medline].

22. Moghetti P, Tosi F, Tosti A. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab. Jan 2000;85(1):89-94. [Medline].

23. Moran C, Knochenhauer ES, Azziz R. Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal. J Endocrinol Invest. Nov 1998;21(10):707-20. [Medline].

24. Muderris II, Bayram F, Sahin Y. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism. Fertil Steril. Oct 1997;68(4):644-7. [Medline].

25. New MI. An update of congenital adrenal hyperplasia. Ann N Y Acad Sci. Dec 2004;1038:14-43. [Medline].

26. Rao S, Malik MA, Wilder L, Mott T. Clinical inquiries. What is the best treatment for mild to moderate acne?. J Fam Pract. Nov 2006;55(11):994-6. [Medline].

27. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. Jan 2004;81(1):19-25. [Medline].

28. Seifer DB. Daya S, ed. Evidence-based Obstetrics & Gynecology. Vol 1. 1999:112.

29. Serafini P, Ablan F, Lobo RA. 5 alpha-Reductase activity in the genital skin of hirsute women. J Clin Endocrinol Metab. Feb 1985;60(2):349-55. [Medline].

30. Smith SR, Piacquadio DJ, Beger B, Littler C. Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial. Dermatol Surg. Oct 2006;32(10):1237-43. [Medline].

31. Stanczyk FZ. Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab. Jun 2006;20(2):177-91. [Medline].

32. Steinberger E, Rodriguez-Rigau LJ, Smith KD. The prognostic value of acute adrenal suppression and stimulation tests in hyperandrogenic women. Fertil Steril. Feb 1982;37(2):187-92. [Medline].

33. Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. Sep-Oct 2006;19(5):272-9. [Medline].

34. Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane Database Syst Rev. 2003;(4):CD001125. [Medline].

35. Wild RA. Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. Jan 16 1995;98(1A):27S-32S. [Medline].

36. Witkowski JA, Parish LC. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol. Sep-Oct 2004;22(5):394-7. [Medline].

Further Reading

Keywords

androgen excess, excessive androgen production, adrenal glands, ovary, endocrine glands, testosterone, dihydrotestosterone, DHT, dehydroepiandrosterone sulfate, DHEAS, dehydroepiandrosterone (DHEA), androstenedione, androstenediol luteinizing hormone, LH, adrenocorticotropic hormone, ACTH, 11-androstenedione, adrenal androgen secretion, albumin, sex hormone-binding globulin, SHBG, congenital adrenal hyperplasia, CAH, enzyme defect, adrenal steroid hormone, cortisol, aldosterone, hyperandrogenism, deoxycorticosterone, DOC, hypertension, hypokalemia, hydroxylase deficiency, 3α-hydroxy-steroid dehydrogenase deficiency, pregnenolone, 17-hydroxy-pregnenolone, cardiovascular disease, CVD, acanthosis nigricans, hirsutism, polycystic ovarian syndrome, PCOS, hyperthecosis, Sertoli-Leydig cell tumor, hilus cell tumor, lipoid cell tumor

Contributor Information and Disclosures

Author

Luca Sabatini, MD, MRCOG, Consultant in Obstetrics and Gynecology, Specialist in Reproductive Medicine and Surgery, St Bartholomew's Hospital and London NHS Trust, UK
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Richard S Legro, MD, Professor, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Pennsylvania State University College of Medicine; Consulting Staff, Milton S Hershey Medical Center
Richard S Legro, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, Endocrine Society, Phi Beta Kappa, and Society of Reproductive Surgeons
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Bryan D Cowan, MD, Professor and Chairman, Department of Obstetrics and Gynecology, University of Mississippi College of Medicine; Consulting Staff, Department of Obstetrics and Gynecology, Veterans Affairs Medical Center; Medical Director, Wiser Hospital for Women, University of Mississippi Medical Center
Bryan D Cowan, MD is a member of the following medical societies: American Association of Gynecologic Laparoscopists, American College of Obstetricians and Gynecologists, American Gynecological and Obstetrical Society, American Medical Association, American Society for Reproductive Medicine, Association of Professors of Gynecology and Obstetrics, Central Association of Obstetricians and Gynecologists, Endocrine Society, Sigma Xi, Society for Assisted Reproductive Technologies, Society for Gynecologic Investigation, Society for the Study of Reproduction, and Society of Laparoendoscopic Surgeons
Disclosure: Wyeth None Speaking and teaching